[1]
“Dextran Conjugation of Non–Steroidal Anti-Inflammatory Drug (Etodolac): A Colon Targeting Approach: Development of a Glucosamine-conjugated Etodolac Prodrug for Improved Targeting and Reduced Side Effects”, JASRAE, vol. 16, no. 6, pp. 3589–3595, May 2019, Accessed: Apr. 04, 2026. [Online]. Available: https://ignited.in/index.php/jasrae/article/view/11970